FibroGen Inc header image

FibroGen Inc

FGEN

Equity

ISIN US31572Q8087 / Valor 25953994

NASDAQ (2024-11-21)

USD 0.39+10.6%

FibroGen Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

FibroGen Inc is a biopharmaceutical company focused on developing innovative therapies for various medical conditions. One of their potential first-in-class products is FG-3246, an antibody-drug conjugate being developed for metastatic castration-resistant prostate cancer and other tumor types. Another promising drug in their pipeline is Pamrevlumab, a human monoclonal antibody designed to inhibit the activity of connective tissue growth factor in proliferative disorders and certain cancer cell types. Additionally, FibroGen is working on Roxadustat, an oral small molecule inhibitor for treating chemotherapy-induced anemia. These investigational drugs are at various stages of clinical development and have the potential to address significant unmet medical needs in the market.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-20.9%1Y

-96.8%3Y

-99.0%5Y

Performance

153%1Y

148%3Y

126%5Y

Volatility

1566 M

Market cap (USD)

404,125

Daily traded volume (Shares)

0.3888 / 0.3365

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals Inc Valor: 30132056

Annual Return

-50%0%+50%

Risk level

110

0.95%USD 27.75

ICU Medical Inc

ICU Medical Inc Valor: 940704

Annual Return

-50%0%+50%

Risk level

110

0.75%USD 168.84

CRISPR Therapeutics Ltd

CRISPR Therapeutics Ltd Valor: 33408113

Annual Return

-50%0%+50%

Risk level

110

-2.05%USD 46.29

Surgery Partners Inc

Surgery Partners Inc Valor: 29308003

Annual Return

-50%0%+50%

Risk level

110

3.73%USD 23.35

Merit Medical Systems Inc

Merit Medical Systems Inc Valor: 951136

Annual Return

-50%0%+50%

Risk level

110

0.91%USD 105.03

Premier Inc

Premier Inc Valor: 22227168

Annual Return

-50%0%+50%

Risk level

110

0.85%USD 22.42

Lantheus Holdings Inc

Lantheus Holdings Inc Valor: 24784644

Annual Return

-50%0%+50%

Risk level

110

1.01%USD 87.32

Arrowhead Pharmaceuticals Inc

Arrowhead Pharmaceuticals Inc Valor: 32193461

Annual Return

-50%0%+50%

Risk level

110

-2.30%USD 18.28

Evotec SE

Evotec SE Valor: 3979578

Annual Return

-50%0%+50%

Risk level

110

0.94%USD 5.35

Staar Surgical Co

Staar Surgical Co Valor: 972813

Annual Return

-50%0%+50%

Risk level

110

1.18%USD 26.63

SIX

FactSet

Clearbit

Logos provided by Clearbit